2015
DOI: 10.1039/c5cc02409a
|View full text |Cite
|
Sign up to set email alerts
|

An enhanced ascorbate peroxidase 2/antibody-binding domain fusion protein (APEX2–ABD) as a recombinant target-specific signal amplifier

Abstract: A recombinant target-specific signal amplifier was constructed by genetically fusing the enhanced ascorbate peroxidase 2 (APEX2) and an antibody-binding domain (ABD). The fusion protein APEX2-ABD possessed the peroxidase activity and the antibody-binding capability simultaneously and replaced the conventional HRP-conjugated secondary antibodies in a TSA assay for amplifying fluorescence signals.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 26 publications
0
14
1
Order By: Relevance
“…To complement this new application, we built a recombineering-ready plasmid series for C-terminal protein tagging. Coding regions for the auxin degron (AID 22 ), the fluorescent protein Venus 23 and the enzymes for biotin proximity labeling BirM 24 and APEX2 25 26 have been cloned into the same context in a plasmid series based on the R6K origin. The context includes on the 5′ side a flexible protein linker based on two copies of the Ty1 peptide, which serves two additional purposes.…”
Section: Resultsmentioning
confidence: 99%
“…To complement this new application, we built a recombineering-ready plasmid series for C-terminal protein tagging. Coding regions for the auxin degron (AID 22 ), the fluorescent protein Venus 23 and the enzymes for biotin proximity labeling BirM 24 and APEX2 25 26 have been cloned into the same context in a plasmid series based on the R6K origin. The context includes on the 5′ side a flexible protein linker based on two copies of the Ty1 peptide, which serves two additional purposes.…”
Section: Resultsmentioning
confidence: 99%
“…APEX2 appears ideally suited as a reporter that is compatible with fusion to monomeric and dimeric sdAb targeted to the periplasm. While the cytosolic expression of APEX2 fused to the antibody binding domain of protein A was successful [30], being able to express high levels of a peroxidase in the E. coli periplasm immediately facilitates genetic fusion to any recombinant antibody of choice, not only specific for other filoviral proteins but any antigen of interest. In contrast, the cytosolic expression of recombinant antibody fragments, even in hosts engineered to have oxidizing cytosols to enable disulfide bond formation, can be fickle with success very much on a case-by-case basis even within the highly soluble single-domain family of antibodies [31].…”
Section: Discussionmentioning
confidence: 99%
“…Since the genetically encoded mAPEX2 was expressed in the tissue and compatible with microwave-enhanced chemical fixation containing glutaraldehyde, it replaced the use of pre-embedding antibody labeling to identify rAAV-targeted axons. mAPEX2 accommodates tyramide-conjugated fluorescent dyes, which are then deposited in the targeted cells by the TSA reaction [55]. The combination of mAPEX2-driven TSA reaction and post-embedding immunogold labeling allowed reliable identification of the targeted cells throughout the 50 μm vibraslices, at depths not accessible by pre-embedding antibody methods (< 10 μm).…”
Section: Mapex2 Labeled Axons Are Compatible With Ultrastructural Anamentioning
confidence: 99%